Drug titration patterns and HbA(1c) levels in type 2 diabetes

OBJECTIVE: To evaluate oral antidiabetes drug (OAD) use, haemoglobin A(1c) (HbA(1c)) testing and glycaemic control in type 2 diabetes patients. STUDY DESIGN: Retrospective analysis based on claims data from the Integrated Healthcare Information Services (IHCIS) National Managed Care Benchmark Databa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross Maclean, J, Chapman, R H, Ferrufino, C P, Krishnarajah, G
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2009
Materias:
Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984545/
https://www.ncbi.nlm.nih.gov/pubmed/19570118
http://dx.doi.org/10.1111/j.1742-1241.2009.02094.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984545/
https://www.ncbi.nlm.nih.gov/pubmed/19570118
http://dx.doi.org/10.1111/j.1742-1241.2009.02094.x

Ejemplares similares